InvestorsHub Logo
Followers 13
Posts 1106
Boards Moderated 0
Alias Born 02/01/2023

Re: georgejjl post# 415070

Friday, 05/12/2023 12:54:30 PM

Friday, May 12, 2023 12:54:30 PM

Post# of 463369
Well, we'll see. It was a small trial, which will make the FDA hesitant, and I have doubts that ADCS-ADL clearly, strongly met its pre-specified endpoints. I'm very pleased with and optimistic currently about the AA+new-P3 approach. I think we very likely have an AD drug coming to market and that the confirmatory trial will satisfy the FDA.

But if the P2b/3 results were that amazingly "VERY STRONG," George, then why do you think Missling is wasting time and money dicking around with planning an additional trial? Did you get the memo but he didn't?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News